HOUSTON INNOVATORS PODCAST EPISODE 55

New awards to 'pay homage' to Houston's tech scene

Houston Exponential's Harvin Moore and Serafina Lalany join this week's Houston Innovators Podcast to discuss The Listies. Photos courtesy

The deadline for nominations has been extended to November 6. The original story below has been edited to reflect the extension.

With so much of 2020 going wrong, a new awards program is hoping to shine a spotlight on Houston tech startups and other major innovation players who are doing things right.

The Listies nominations are open online until this Friday, November 6, and are being hosted by Houston Exponential in partnership with InnovationMap.

"The idea for The Listies has been in the back of our minds for a long time," says Serafina Lalany, chief of staff at HX, on this week's episode of the Houston Innovators Podcast. "There has always been a need in the ecosystem to celebrate the wins and vibrant culture we have here. This is an opportunity to pay homage to that."

The 12 awards will recognize growing startups, individuals, mentors, corporations, investors, and more. Award eligibility requires nominees to have an account on HX's new platform, the HTX TechList, which is free to use and is intended to be a virtual meeting place and resource for Houston innovation.

The honorees will be awarded at a virtual event ceremony at 3 pm on Friday, November 30. The event is hoping to duplicate the engagement the organization saw at its HTX TechList launch in August, which had over 1,000 registrants and a message from Mayor Sylvester Turner.

"This ecosystem really eats up events — even if they are virtual," says Harvin Moore, president of HX, on the podcast. "This will be another opportunity for the organizations and all the people in the ecosystem to get together. ... It's also an opportunity to continue to develop what's happening in Houston."

The event is gathering tech and innovation influencers to promote and play a role in the event — from judges to award presenters. The program is also seeking sponsors to be included in the event as well.

"HX's true strength is bringing people together around a common mission, and this is very true to that," Lalany says.

Listen to the full interview below — or wherever you stream your podcasts — and subscribe for weekly episodes.


Trending News

Building Houston

 
 

Dr. Peter Hotez and Dr. Maria Elena Bottazzi have been recognized by Fast Company for their leadership in developing low-cost COVID vaccine. Photo courtesy of Texas Children's

This week, Fast Company announced its 14th annual list of Most Creative People in Business — and two notable Houstonians made the cut.

Dr. Peter Hotez and his fellow dean of the National School of Tropical Medicine at Baylor College of Medicine, Dr. Maria Elena Bottazzi, were named among the list for “open sourcing a COVID-19 Vaccine for the rest of the world.” The list, which recognizes individuals making a cultural impact via bold achievements in their field, is made up of influential leaders in business.

Hotez and Bottazzi are also co-directors for the Texas Children's Hospital's Center for Vaccine Development -one of the most cutting-edge vaccine development centers in the world. For the past two decades it has acquired an international reputation as a non-profit Product Development Partnership (PDP), advancing vaccines for poverty-related neglected tropical diseases (NTDs) and emerging infectious diseases of pandemic importance. One of their most notable achievements is the development of a vaccine technology leading to CORBEVAX, a traditional, recombinant protein-based COVID-19 vaccine.

"It's an honor to be recognized not only for our team's scientific efforts to develop and test low cost-effective vaccines for global health, but also for innovation in sustainable financing that goes beyond the traditional pharma business model," says Hotez in a statement.

The technology was created and engineered by Texas Children's Center for Vaccine Development specifically to combat the worldwide problem of vaccine access and availability. Biological E Limited (BE) developed, produced and tested CORBEVAX in India where over 60 million children have been vaccinated so far.

Earlier this year, the doctors were nominated for the 2022 Nobel Peace Prize for their research and vaccine development of the vaccine. Its low cost, ease of production and distribution, safety, and acceptance make it well suited for addressing global vaccine inequity.

"We appreciate the recognition of our efforts to begin the long road to 'decolonize' the vaccine development ecosystem and make it more equitable. We hope that CORBEVAX becomes one of a pipeline of new vaccines developed against many neglected and emerging infections that adversely affect global public health," says Bottazzi in the news release from Texas Children's.

Fast Company editors and writers research candidates for the list throughout the year, scouting every business sector, including technology, medicine, engineering, marketing, entertainment, design, and social good. You can see the complete list here

.

Trending News